Diadexus Inc (DDXS) 0.0130 $DDXS Diadexus, Inc. to File

New Post Public Reply Private Reply Replies (0) Message Board

Jun 23, 2016 at 12:12 AM

Diadexus Inc (DDXS) 0.0130 $DDXS

Diadexus, Inc. to File Chapter 7
Marketwired - Fri Jun 10, 1:07PM CDT
SOUTH SAN FRANCISCO, CA--(Marketwired - Jun 10, 2016) - Diadexus, Inc. (OTCQB: DDXS), a diagnostics company developing and commercializing products that aid in assessing the prognosis of cardiac disease, today announced that it is filing for relief under Chapter 7 of Title 11 of the US Bankruptcy Code in order to initiate an orderly liquidation of the assets of the Company. The Company has been notified that its lender, Oxford Finance LLC, exercised certain of its rights under the August 2014 Loan and Security Agreement, including with respect to acceleration of obligations and demand for repayment and the removal of all of the available cash and investments from the accounts of the Company.

Diadexus, Inc. and Sonic Healthcare USA Sign National Agreement for PLAC(R) Activity Test
Marketwire Canada - Mon May 23, 8:00AM CDT
Partnering With Fifth Largest U.S. Laboratory Service Provider to Launch Broadly the PLAC(R) Activity Test, an FDA-Cleared Test for Coronary Heart Disease Risk Assessment

Diadexus, Inc. Reports First Quarter 2016 Financial Results
Marketwired - Thu Apr 28, 3:15PM CDT
Diadexus, Inc. (OTCQB: DDXS), a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, today announced financial results for the first quarter ended March 31, 2016 and provided an update on its business.

Diadexus, Inc. Previews First Quarter 2016 Financial Performance and Provides Business Update
Marketwired - Mon Apr 18, 8:15AM CDT
Diadexus, Inc. (OTCQB: DDXS), a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, today announced preliminary financial performance metrics for the first quarter ended March 31, 2016 and provided an update on its business.

Updated - Diadexus, Inc. Reports Fourth Quarter and Full Year 2015 Financial Results
Marketwired - Mon Mar 28, 6:17PM CDT
Diadexus, Inc. (OTCQB: DDXS) -- The enclosed Condensed Statements of Operations and the Condensed Balance Sheets are updated for appropriate classification of three line items.

Diadexus, Inc. Reports Fourth Quarter and Full Year 2015 Financial Results
Marketwired - Mon Mar 28, 3:00PM CDT
Diadexus, Inc. (OTCQB: DDXS), a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, today announced financial results for the fourth quarter and year ended December 31, 2015 and provided an update on its business.

What Awaits Akers Biosciences (AKER) in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon Mar 28, 8:10AM CDT
Akers Biosciences Inc (AKER) is expected to report fourth-quarter 2015 earnings results on Mar 30.
AMZN: 710.60 (-5.22), AXDX: 15.29 (-0.09), AKER: 2.10 (-0.03)

LeMaitre Vascular (LMAT) Looks Good: Stock Rises 8%
Zacks Equity Research - Zacks Investment Research - Mon Dec 07, 7:30AM CST
LeMaitre Vascular, Inc. (LMAT) was a big mover last session, as the company saw its shares rise slightly over 8% on the day.
LMAT: 14.69 (+0.15)

Bovie Medical (BVX) Catches Eye: Stock Rises 6.4%
Zacks Equity Research - Zacks Investment Research - Thu Nov 12, 7:30AM CST
Bovie Medical Corporation (BVX) was a big mover last session, as the company saw its shares rise over 6% on the day.
BVX: 1.70 (unch)

VWR Corp Looks Good on Strategic Initiatives: Add to Portfolio
Zacks Equity Research - Zacks Investment Research - Tue Nov 10, 1:15PM CST
On Nov 9, 2015, we issued an updated research report on VWR Corporation (VWR).
SRDX: 23.35 (+0.16), NXTM: 19.38 (-0.54), VWR: 30.03 (-0.15)

Diadexus, Inc. Presents New PLAC(R) Activity Data From the REGARDS Study at 2015 American Heart Association Scientific Sessions
Marketwired - Tue Nov 10, 8:01AM CST
Diadexus, Inc. (OTCQB: DDXS), a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, today announced a poster presentation at the 2015 American Heart Association (AHA) Scientific Sessions taking place November 7-11, 2015 in Orlando, FL.

Hill-Rom (HRC) Poised on Organic Growth, Long-Term Targets
Zacks Equity Research - Zacks Investment Research - Mon Nov 09, 1:30PM CST
On Nov 6, 2015, we updated our research report on medical device company Hill-Rom Holdings, Inc. (HRC).
SRDX: 23.35 (+0.16), NXTM: 19.38 (-0.54), HRC: 51.28 (+0.16)

Hill-Rom Beats on Q4 Earnings, Revenues; FY16 View Strong
Zacks Equity Research - Zacks Investment Research - Fri Nov 06, 9:15AM CST
Hill-Rom Holdings, Inc. (HRC) reported fourth-quarter fiscal 2015 adjusted earnings per share (EPS) of 83 cents, up 12.2% from the year-ago quarter.
SRDX: 23.35 (+0.16), OFIX: 44.33 (-0.42), HRC: 51.28 (+0.16)

BioScrip Q3 Loss Wider than Expected; Strategic Plan in Focus
Zacks Equity Research - Zacks Investment Research - Thu Nov 05, 12:45PM CST
BioScrip, Inc. (BIOS) reported adjusted net loss from continuing operations of 19 cents per share in the third quarter of 2015.
SRDX: 23.35 (+0.16), BIOS: 2.78 (-0.01), HRC: 51.28 (+0.16)

Alere Lags Q3 Earnings, Revenue Estimates; Cuts 2015 View
Zacks Equity Research - Zacks Investment Research - Thu Nov 05, 12:30PM CST
Alere Inc. (ALR) reported adjusted earnings (including share based compensation) of 51 cents per share in the third quarter of 2015.
SRDX: 23.35 (+0.16), ALR: 42.40 (-0.10), HRC: 51.28 (+0.16)

NxStage Medical Q3 Loss Narrower than Expected, View Up
Zacks Equity Research - Zacks Investment Research - Wed Nov 04, 12:55PM CST
NxStage Medical Inc. (NXTM) reported adjusted loss of 3 cents per share in the third quarter of 2015.
ICUI: 104.98 (+0.28), NXTM: 19.38 (-0.54), HRC: 51.28 (+0.16)

Diadexus, Inc. Reports Third Quarter 2015 Financial Results
Marketwired - Mon Oct 26, 3:05PM CDT
Diadexus, Inc. (OTCQB: DDXS), a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, today announced financial results for the nine months and quarter ended September 30, 2015, and provided an overview of recent corporate achievements and milestones.

Diadexus, Inc. Names Jonathan Ruais as Vice President of Marketing
Marketwired - Tue Oct 13, 8:15AM CDT
Diadexus, Inc. (OTCQB: DDXS), a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, today announced that Jonathan Ruais has joined the Company as Vice President of Marketing. Mr. Ruais brings over 15 years of leadership experience to Diadexus, including nearly 10 years as a highly accomplished marketing executive in the medical industry. In his new role at Diadexus, Mr. Ruais will be responsible for developing and executing the Company's marketing programs, including helping drive awareness and adoption of PLAC(R) Activity within the hospital and lab channels and supporting the launch of proADM for acute episodes of heart failure.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CFDA Fashion Awards: Stars Align for High-Stakes Night

A Night of Glamour and Recognition Fashion's upper crust pulled out all the stops at the 2026 CFDA Fashion Awards, presented by Amazon Fashion. Amidst glittering gowns and sharp tuxedos, recognition was the order of the night at an event held at the American Museum of Natural History. What you got was an industry tip of the hat to the visionaries pushing boundaries in...

Sandals & Beaches Black Friday: Up to 65% Savings

Vacation Savings So Sweet They’re Hard to Ignore If you’ve been dreaming of a sun-soaked escape, Sandals and Beaches Resorts have rolled out deals so compelling, they’re practically begging you to pack your bags. This year, from November 3 until December 1, travelers can dive into savings of up to 65% combined with air credits reaching up to $750. In a move clearly...

AppLovin Faces Lawsuit: Investor Unrest Unfolds

Shaky Ground Beneath AppLovin's Feet Ah, the sweet smell of litigation in the tech space—it’s like déjà vu for seasoned market folks. Here we have AppLovin, nestled comfortably in San Francisco, now eying a saucy class-action lawsuit. We're looking at shareholders taking a firm stance against some arguably misleading claims. We're talking big deals with allegations...

Verra Mobility Welcomes New CEO with $4.75M Stock Grant

New Crossroad for Verra Mobility Verra Mobility Corporation, the outfit making all those city intersection nightmares a bit more bearable, just rolled out the red carpet for Jon Newhard, their new head honcho. November 2, 2026, was the big day, but this isn’t just a pat on the back. We're talking a cushy entry with a one-off award that's not for chump change. Think of...

GNSS Simulator Market: $425M by 2031, Key Insight

GNSS Simulator Market: Gadgets Meet Growth A market that's been quietly bubbling away on the back burner is about to boil over: The GNSS Simulator Market, pegged at a neat $424.6 million by 2031. Yeah, it might be niche, but those in the know can't get enough of these satellite-signal replicators. Why GNSS Simulators are Crushing It There's a bunch of reasons why GNSS...

Midterms Stir Markets; Event Contracts Fuel Q3 Gains

Midterms Mingle with Financial Markets Folks, throw those ballots into the ring, because today the midterms are kicking things off and boy, are they shaking up the game on these prediction markets. Traders and exchanges are on their toes, and the money's flowing like cold brew in July. Robinhood, Intercontinental Exchange, CME Group, and others reported noticeable ripples...

Rising Medical Lands Ninth Spot on Inc. 5000

Rising Medical's Continued Ascent In a world where the list of high-performing companies is as long as a trader's bad day, Rising Medical Solutions, out of Chicago, has snagged its ninth appearance on the Inc. 5000 list. This isn’t just any roll call; we're talking about a spotlight for America’s fastest-growing private companies—a badge of honor for business...

Cboe Fights CFTC Over Single-Stock Derivative Approval

The Battle Begins: Cboe's Legal Action Cboe Global Markets, the big kahuna in the equities and index derivatives scene, ain't just rolling over quietly. They've hopped on board with the Capital Markets Alliance in a legal dust-up against the Commodity Futures Trading Commission's (CFTC) decision to allow perpetual derivatives on U.S. stocks and ETFs. We're talking major...

Yunji Rolls Out AI Robots at EquipHotel Paris 2026

AI Takes Center Stage in Hospitality When someone mentions a new revolution in hospitality, I usually roll my eyes. But this time, Yunji Technology (HKEX: 02670) is bringing something to the table that's hard to ignore. They’re out in full force at EquipHotel Paris 2026, flaunting their AI-powered collection of service bots with the kind of confidence that says, 'We're...

BAIC FOTON Expands With New Trucks in Africa

Innovation in African Mobility Amidst the sparse horizons of Port Elizabeth, South Africa, BAIC FOTON is shifting gears in a big way. They've rolled out a duo of heavy-duty trucks—the GALAXUS R5 and C5—and topped it off with the TUNLAND V PHEV plug-in hybrid pickup. On October 29, the Africa Regional Partner Conference buzzed with talk of 'Driving to Great,' signaling...